The lateral parabrachial nucleus (LPBN) exerts an important inhibitory influence for the control of sodium and water intake. However, the importance of LPBN on renal responses and cardiovascular changes during extracellular dehydration are still unknown. Here we investigated the effects of bilateral injections of moxonidine (alpha 2 -adrenergic and imidazoline receptor agonist) on renal and cardiovascular changes in fluid-depleted rats. Male Wistar rats (n = 4-8 per group) with bilateral stainless steel guide-cannulas implanted into the LPBN were treated with subcutaneous furosemide (10 mg/kg) + captopril (5 mg/kg) to induce fluid depletion. Forty-five min later vehicle or moxonidine (0.5 nmol/0.2 l) were bilaterally injected into the LPBN. In fluid-depleted rats, moxonidine produced strong 0.3 M NaCl and water intake without noticeable changes in cardiovascular parameters. Moxonidine did not change sodium excretion (488 ± 135, vs. vehicle: 376 ± 75 Eq/1 h) or urinary volume (2.5 ± 0.7, vs. vehicle: 2.5 ± 0.3 ml/1 h) in fluid-depleted rats without access to fluids for rehydration. However, moxonidine decreased natriuresis (462 ± 127, vs. vehicle: 888 ± 122 Eq/1 h) and diuresis (2.5 ± 0.5, vs. vehicle: 4.5 ± 0.5 ml/1 h) in fluid-depleted rats submitted to i.g. rehydration. These data suggest that alpha 2 -adrenergic mechanism of the LPBN facilitates sodium/water retention and body fluid volume expansion during extracellular dehydration.
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Introduction
The lateral parabrachial nucleus (LPBN) integrates and relays taste and visceral signals that ascend from AP/mNTS to the forebrain areas involved in the control of fluid and electrolyte balance (Ciriello et al., 1984; Fulwiler and Saper, 1984; Herbert et al., 1990; Jhamandas et al., 1992; Jhamandas et al., 1996; Krukoff et al., 1993; Lanca and van der Kooy, 1985; Norgren, 1981) . This bilateral pontine structure is responsible for important inhibitory mechanisms for the control of water and NaCl intake [for review see Andrade et al., 2014; Johnson and Thunhorst, 2007; Menani et al., 2014] .
The alpha 2 -adrenoceptor/imidazoline receptor agonist moxonidine injected into the LPBN strongly enhances the sodium appetite of acutely sodium-depleted rats, but has no effect on sodium intake of hydrated and satiated rats (Andrade et al., 2004) . Bilateral injections of noradrenaline or the specific ␣ 2 -adrenoceptor agonist
